PBE241220C56000
- 0.00
- 0.000.00%
Invesco Biotechnology & Geno Funds Newsroom
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Sarepta Awarded $115.2M in Vyondys 53 Patent Case: Report
Traders Fight The Grinch To Save The Santa Rally: 10 S&P 500 Stocks Poised For A Year-End Surge
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
What's Going On With Amgen Stock On Friday?
Needham Reiterates Hold on Neurocrine Biosciencesto Hold
Neurocrine Biosciences Analyst Ratings
Why Is Novo Nordisk Crashing After Data for Next-gen Weight Loss Drug?
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Amgen Shares Are Trading Higher. Weight-loss Related Stocks Are up on Friday Following Weaker-than-expected Data From Competitor Lilly.
The weight loss effect of the new drug was below expectations, and Novo-Nordisk A/S saw its stock plummet by 28% in Pre-Market Trading, while competitor Eli Lilly and Co surged over 12%.
The experimental results show that patients who received subcutaneous injections of CagriSema lost an average of 22.7% of their weight after 68 weeks. If volunteers who dropped out of the trial are included, the average weight loss effect decreases to 20.4%, both below the company's previous expectation of 25%.
BMO Capital Downgrades Biogen to Market Perform, Lowers Price Target to $164
Biogen Analyst Ratings
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
The Analyst Verdict: Incyte In The Eyes Of 15 Experts
(GILD) - Analyzing Gilead Sciences's Short Interest
Regeneron Reports Positive Results for Two Anti-coagulant Drugs